DePuy ASR Settlement Enrollment Deadline Extended Until September 30, 2014, Bernstein Liebhard LLP Reports

The Firm represents a number of DePuy ASR hip lawsuit clients who suffered chronic pain, metallosis, premature device failure and other serious complications allegedly due to the recalled metal-on-metal hip replacements.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
Our Firm is representing DePuy ASR lawsuit clients who may be eligible for compensation under this settlement agreement.

New York, New York (PRWEB) August 27, 2014

The federal judge overseeing thousands of DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) has extended the deadline for plaintiffs to enroll in the U.S. Settlement Program. According to an August 2014 Order issued by U.S. District Judge David Katz of the Northern District of Ohio, those wishing to enroll in the DePuy ASR Settlement Program must do so by September 30, 2014. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“Our Firm is representing DePuy ASR lawsuit clients who may be eligible for compensation under this settlement agreement,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who allegedly experienced metallosis, chronic pain, disability, premature hip implant failure, and other serious complications allegedly related to devices included in the DePuy ASR recall.

DePuy ASR Lawsuits
According to a Bloomberg.com report published last November, the DePuy ASR hip recall was issued after data indicated that 12% of the metal-on-metal hips were failing within just five years of implantation. However, more recent data indicates that the actual early failure rate associated with the devices could reach as high as 44%. Since the recall was announced, court documents indicate that thousands of people have filed DePuy ASR lawsuits seeking compensations for injuries allegedly caused by the devices.*

Court filings show that the DePuy ASR settlement was proposed in the Northern District of Ohio last November, and would resolve some 8,000 of the 12,000 complaints filed since the recall. In May, Johnson & Johnson, the parent company of DePuy Orthopaedics, waived its “walk away rights” after a majority of eligible claimants agreed to accept the terms of the settlement, paving the way for the settlement to be finalized.

According to court documents, plaintiffs qualified to participate in the DePuy ASR settlement program include those who underwent revision surgery to replace their ASR hip due to a recall-related reason prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience "certain extraordinary injuries" in the future. Plaintiffs who do not wish to participate, or those who are not eligible, will still be permitted to pursue individual claims against the companies.

Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about the DePuy ASR litigation, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

*bloomberg.com/news/2013-11-19/j-j-unveils-hip-accord-that-may-be-worth-more-than-4-bln.html, Bloomberg.com, November 19, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author